Valeant (VRX) Investors You Have One Move To Make: Run!

By |November 2nd, 2015|

Valeant Pharmaceuticals Intl Inc (NYSE: VRX)
According to the news, Valeant Pharmaceuticals has been having a rough time in the market as of late, and rightfully so. Recently, Citron published a report claiming that VRX was the Enron of the pharmaceutical industry. When the report was first published, like most investors, I didn’t want to […]